Biofourmis
Seth Kuzdzal is an accomplished professional in Quality Assurance and Regulatory Affairs, currently serving as the Senior Vice President at Biofourmis since June 2022, where leadership focuses on quality and regulatory strategy for digital health solutions. Prior roles include Vice President and Head of Quality Assurance and Regulatory Affairs at Akili Interactive, and Head of Quality Assurance and Regulatory Affairs for Philips' Population Healthcare Management. Seth has extensive experience in leading quality initiatives across multiple organizations, including Covidien (Medtronic), Medtronic, Boston Scientific, C.R. Bard Endoscopic Technologies, and GE Healthcare. An MBA graduate from Babson F.W. Olin Graduate School of Business and a Bachelor’s in Biomedical Engineering from Texas A&M University, Seth has a solid educational foundation underpinning a significant career dedicated to enhancing healthcare quality and compliance.
This person is not in any teams
This person is not in any offices
Biofourmis
6 followers
Biofourmis is a fast-growing digital health company filled with committed, passionate people who care about augmenting personalized care and empowering people with complex chronic conditions to live better and healthier lives. They are pioneering an entirely new category of medicine, by developing clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Biofourmis has built Biovitals®, a highly sophisticated personalized AI-powered health analytics platform that predicts clinical exacerbation in advance of a critical event, which is the backbone of their digital therapeutics’ product pipeline across multiple therapeutic areas—including heart failure, oncology, acute coronary syndrome, COPD and chronic pain.